Summary:
A 25-year epidemiological study of more than 500,000 UK adults published in Neurology reveals that living near industrial facilities reporting water pollution is associated with a significantly increased risk of developing progressive supranuclear palsy (PSP). Led by Harvard Medical School researchers, the investigation found that individuals living within three miles of sites releasing pesticides, inorganic pollutants, organic compounds, or heavy metals faced up to a 66% higher likelihood of developing this rare, rapid neurodegenerative movement disorder. Risk decreased progressively with greater residential distance from polluting facilities.
Key Facts:
- 66% Elevated Pesticide Risk: Individuals living within roughly three miles of facilities releasing pesticides (such as atrazine, simazine, and diuron) had a 66% higher likelihood of developing PSP compared to those living farther away.
- Proximity Gradients: Risk showed a dose-response pattern, attenuating in proportion to residential distance up to six miles away, while duration of residence near polluting facilities also correlated with disease risk.
- Broad Environmental Classes: Statistically significant elevations in PSP incidence were documented near facilities emitting inorganic pollutants (60%), organic compounds like benzene and toluene (52%), and heavy metals like lead and cadmium (38%).
Source: American Academy of Neurology / Harvard Medical School
Progressive supranuclear palsy (PSP) is a severe, rare neurodegenerative disorder classified within the family of atypical parkinsonian syndromes. While PSP shares motor features with Parkinson’s disease, such as postural instability, stiffness, and bradykinesia, it follows a much faster, relentless trajectory, marked by early falls, vertical gaze palsy, executive cognitive decline, and poor responsiveness to dopaminergic medications.
While the pathology of PSP is characterized by abnormal accumulations of four-repeat (4R) tau protein within basal ganglia and brainstem circuits, its underlying triggers remain elusive, with environmental contributors long suspected but rarely pinned down.
Now, a population-based longitudinal investigation published October 28, 2026, in Neurology®, the medical journal of the American Academy of Neurology, provides empirical evidence linking ambient industrial water contamination to the development of PSP.
Led by Charlie Weige Zhao, MD, of Harvard Medical School and Massachusetts General Hospital in Boston, the research team tracked environmental exposures across a prospective cohort of more than 500,000 adults in the United Kingdom over a 25-year follow-up period.
Mapping Industrial Proximity Across 25 Years
Over the 25-year monitoring window, 221 individuals developed clinically confirmed progressive supranuclear palsy. To evaluate environmental risk, the investigators matched each patient with PSP to 10 healthy control participants based on age and biological sex.
Using baseline residential address data documented in 2007, the researchers geocoded how close individuals lived to regulated industrial sites that officially reported water pollutant emissions. Facilities examined included wastewater treatment centers, intensive aquaculture sites, chemical production plants, and thermal power generation stations.
The analysis tracked six distinct classes of environmental pollutants: heavy metals, chlorinated solvents, persistent organic pollutants, agricultural pesticides, other organic pollutants, and other inorganic compounds. Participants residing at their addresses for less than one year were excluded from the analysis.
The spatial analysis revealed that approximately one-third of individuals who developed PSP lived within three miles of an industrial polluting facility, compared to approximately one-quarter of control participants.
Pollutant Breakdown: Pesticides and Heavy Metals
After controlling for potential confounders including participant age, biological sex, and socioeconomic/educational attainment levels, residential proximity to specific industrial effluent categories showed distinct risk profiles:
- Agricultural Pesticides: Residents living within three miles of facilities discharging pesticides, including atrazine, simazine, and diuron, demonstrated a 66% increased risk of developing PSP.
- Inorganic Pollutants: Living near sites emitting inorganic compounds, such as fluorides, phosphorus, and nitrogen derivatives, was associated with a 60% increased risk.
- Organic Compounds: Proximity to sources releasing volatile and semi-volatile organics, such as benzene, ethylbenzene, and toluene, was associated with a 52% higher risk.
- Heavy Metals: Individuals situated near facilities releasing heavy metals, including cadmium, lead, and mercury, exhibited a 38% elevated risk.
In contrast, no statistically significant associations were identified between residential proximity to facilities releasing chlorinated solvents or persistent organic pollutants and the subsequent emergence of PSP.
“These results suggest that environmental water pollutants potentially play a role in the development of progressive supranuclear palsy,” said Dr. Zhao. “Further studies are needed to confirm these findings, but this is a step forward in understanding what raises a person’s chance of getting PSP.”
Distance-Decay Effects and Toxicological Considerations
Importantly, the researchers noted a distance-decay effect: the elevated risk of PSP steadily attenuated as geographical distance from industrial sites lengthened, with associations tapering off beyond approximately six miles. Moreover, the cumulative duration of time an individual resided within these industrial radii played a corresponding role in their likelihood of disease diagnosis.
Dr. Zhao emphasized that because progressive supranuclear palsy is an exceedingly rare condition, affecting roughly 5 to 6 individuals per 100,000, the absolute lifetime risk for any given person remains low, even among those residing near industrial facilities.
The authors note several epidemiological limitations. The study design establishes a statistical association rather than direct biological causation. Detailed occupational histories were unavailable, precluding analysis of workplace-specific chemical exposures. Additionally, because many industrial operations emit complex mixtures of multiple chemicals simultaneously, isolating the toxicological contribution of any individual chemical compound was not feasible.
The findings provide clinical support for toxicological research evaluating how industrial chemicals penetrate the blood-brain barrier and trigger tauopathy, while highlighting the need for clean water infrastructure and tighter environmental regulatory oversight.
Funding: The study was supported by the Dolce Family Fund for PSP research at Massachusetts General Hospital.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper will be reviewed in full upon release.
- Additional context added by our staff.
About this PSP and neurology Research:
- Media Contact: Natalie Conrad
- Source: AAN
- Image Credit: Image credited to Neuroscience News
- Original Research is Open Access: The findings will appear in Neurology